Spasticity: A review
暂无分享,去创建一个
[1] Jonathan L. Costa,et al. Ivermectin for spasticity in spinal-cord injury , 1994, The Lancet.
[2] D. Reis,et al. Agmatine: an endogenous clonidine-displacing substance in the brain. , 1994, Science.
[3] M. J. Friedlander,et al. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. , 1994, Science.
[4] R. Young,et al. The effect of nicotine on recurrent inhibition in the spinal cord , 1993, Neurology.
[5] L. Halstead,et al. Relief of spasticity in SCI men and women using rectal probe electrostimulation , 1993, Paraplegia.
[6] Y. Wakayama,et al. Mexiletine for treatment of spasticity due to neurological disorders. , 1993, Muscle & nerve.
[7] L. A. Koman,et al. Management of Cerebral Palsy with Botulinum‐A Toxin: Preliminary Investigation , 1993, Journal of pediatric orthopedics.
[8] A. Thilmann,et al. The limitations of the tendon jerk as a marker of pathological stretch reflex activity in human spasticity. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[9] D. Wolfe,et al. Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury , 1993, Paraplegia.
[10] R. Penn,et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. , 1993, Journal of neurosurgery.
[11] R. Young,et al. Recurrent inhibition is increased in patients with spinal cord injury , 1992, Neurology.
[12] A. Wernig,et al. Laufband locomotion with body weight support improved walking in persons with severe spinal cord injuries , 1992, Paraplegia.
[13] R. Young,et al. Treatment of spasticity with botulinum toxin , 1992, Annals of neurology.
[14] M. Sindou. Microsurgical DREZ-tomy for the treatment of pain and spasticity , 1992 .
[15] P. Delwaide,et al. Quantitative evaluation of the results of restorative neurology , 1992 .
[16] M. Vasko,et al. Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by α-adrenergic receptor antagonists , 1991, Neuropharmacology.
[17] A. Blight,et al. The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. , 1991, Journal of neurotrauma.
[18] D B Calne,et al. Treatment of spasticity with botulinum toxin: A double‐blind study , 1990, Annals of neurology.
[19] F. A. Davis,et al. Orally administered 4‐aminopyridine improves clinical signs in multiple sclerosis , 1990, Annals of neurology.
[20] T. K. Das,et al. Botulinum toxin in treating spasticity , 1989, The British journal of clinical practice.
[21] D. Nance,et al. Reflex changes induced by clonidine in spinal cord injured patients , 1989, Paraplegia.
[22] P. Ashby,et al. Reciprocal inhibition following lesions of the spinal cord in man. , 1989, The Journal of physiology.
[23] M. Latash,et al. Intrathecal Baclofen for Severe Spinal Spasticity , 1989, The New England journal of medicine.
[24] R R Young,et al. Treatment of spastic paresis. , 1989, The New England journal of medicine.
[25] J. Wroblewski,et al. Modulation of glutamate receptors: molecular mechanisms and functional implications. , 1989, Annual review of pharmacology and toxicology.
[26] W Z Rymer,et al. Quantitative relations between hypertonia and stretch reflex threshold in spastic hemiparesis , 1988, Annals of neurology.
[27] S. Rossignol,et al. The effects of clonidine and yohimbine on locomotion and cutaneous reflexes in the adult chronic spinal cat , 1987, Brain Research.
[28] P Ashby,et al. The Evaluation of “Spasticity” , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[29] A Roby-Brami,et al. Long-latency spinal reflex in man after flexor reflex afferent stimulation. , 1987, Brain : a journal of neurology.
[30] D. Corcos,et al. Movement deficits caused by hyperexcitable stretch reflexes in spastic humans. , 1986, Brain : a journal of neurology.
[31] Symposium synopsis , 1986 .
[32] K H Mauritz,et al. Chronic transformation of muscle in spasticity: a peripheral contribution to increased tone. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[33] S. R. Simon,et al. Modification of spastic gait through mechanical damping. , 1982, Journal of biomechanics.
[34] M. Kuhar,et al. Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents , 1984, Brain Research Reviews.
[35] B Conrad,et al. Electromyographic analysis of bicycling on an ergometer for evaluation of spasticity of lower limbs in man. , 1983, Advances in neurology.
[36] R. Lossius. [Drug therapy of spasticity]. , 1981, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[37] J Quintern,et al. Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. , 1981, Brain : a journal of neurology.
[38] R. Tanaka,et al. Reciprocal Ia inhibition in spastic hemiplegia of man. , 1976, Brain : a journal of neurology.
[39] B. Shahani,et al. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions , 1976, Neurology.
[40] W. Landau. Editorial: Spasticity: the fable of a neurological demon and the emperor's new therapy. , 1974, Archives of neurology.
[41] S. Grillner,et al. The locomotion of the acute spinal cat injected with clonidine i.v. , 1973, Brain research.
[42] K. Hagbarth,et al. Muscle spindle responses to stretch in normal and spastic subjects. , 2018, Scandinavian journal of rehabilitation medicine.
[43] D. G. Lawrence,et al. The functional organization of the motor system in the monkey. I. The effects of bilateral pyramidal lesions. , 1968, Brain : a journal of neurology.
[44] D. Munro. Anterior-rootlet rhizotomy; a method of controlling spasm with retention of voluntary motion. , 1952, New England Journal of Medicine.